Heather L Short1, Natalie Taylor2, Kaitlin Piper2, Mehul V Raval3. 1. Division of Pediatric Surgery, Department of Surgery, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA, USA. 2. Rollins School of Public Health, Emory University, Atlanta, GA, USA. 3. Division of Pediatric Surgery, Department of Surgery, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA, USA. Electronic address: mehulvraval@emory.edu.
Abstract
PURPOSE: Despite Enhanced Recovery After Surgery (ERAS) protocols demonstrating improved outcomes in a wide variety of adult surgical populations, these protocols are infrequently and inconsistently being used in pediatric surgery. Our purpose was to develop a pediatric-specific ERAS protocol for use in adolescents undergoing elective intestinal procedures. METHODS: A modified Delphi process including extensive literature review, iterative rounds of surveys, and expert panel discussions was used to establish ERAS elements that would be appropriate for children. The 16-member multidisciplinary expert panel included surgeons, gastroenterologists, anesthesiologists, nursing, and patient/family representatives. RESULTS: Building upon a national survey of surgeons in which 14 of 21 adult ERAS elements were considered acceptable for use in children, the 7 more contentious elements were investigated using the modified Delphi process. In final ranking, 5 of the 7 controversial elements were deemed appropriate for inclusion in a pediatric ERAS protocol. Routine use of insulin to treat hyperglycemia and avoidance of mechanical bowel preparation were not included in the final recommendations. CONCLUSIONS: Using a modified Delphi process, we have defined an appropriate ERAS protocol comprised of 19 elements for use in adolescents undergoing elective intestinal surgery. Prospective validation studies of ERAS protocols in children are needed. LEVEL OF EVIDENCE: Level V, Expert opinion.
PURPOSE: Despite Enhanced Recovery After Surgery (ERAS) protocols demonstrating improved outcomes in a wide variety of adult surgical populations, these protocols are infrequently and inconsistently being used in pediatric surgery. Our purpose was to develop a pediatric-specific ERAS protocol for use in adolescents undergoing elective intestinal procedures. METHODS: A modified Delphi process including extensive literature review, iterative rounds of surveys, and expert panel discussions was used to establish ERAS elements that would be appropriate for children. The 16-member multidisciplinary expert panel included surgeons, gastroenterologists, anesthesiologists, nursing, and patient/family representatives. RESULTS: Building upon a national survey of surgeons in which 14 of 21 adult ERAS elements were considered acceptable for use in children, the 7 more contentious elements were investigated using the modified Delphi process. In final ranking, 5 of the 7 controversial elements were deemed appropriate for inclusion in a pediatric ERAS protocol. Routine use of insulin to treat hyperglycemia and avoidance of mechanical bowel preparation were not included in the final recommendations. CONCLUSIONS: Using a modified Delphi process, we have defined an appropriate ERAS protocol comprised of 19 elements for use in adolescents undergoing elective intestinal surgery. Prospective validation studies of ERAS protocols in children are needed. LEVEL OF EVIDENCE: Level V, Expert opinion.
Authors: Jonathan Vacek; Teaniese Davis; Benjamin T Many; Sharron Close; Sarah Blake; Yue-Yung Hu; Jane L Holl; Julie Johnson; Jennifer Strople; Mehul V Raval Journal: J Pediatr Surg Date: 2020-06-27 Impact factor: 2.545
Authors: Marina L Reppucci; Lea A Wehrli; Julie Schletker; Margo M Nolan; Jared Rieck; Souha Fares; Jill Ketzer; Kyle Rove; Alberto Pena; Luis de la Torre; Andrea Bischoff Journal: Pediatr Surg Int Date: 2022-09-13 Impact factor: 2.003
Authors: Ira L Leeds; Mitchell R Ladd; Margaret H Sundel; Melissa L Fannon; Jessica A George; Emily F Boss; Eric B Jelin Journal: J Pediatr Surg Date: 2018-05-04 Impact factor: 2.545
Authors: Mehul V Raval; Erin Wymore; Martha-Conley E Ingram; Yao Tian; Julie K Johnson; Jane L Holl Journal: Trials Date: 2020-11-16 Impact factor: 2.279